1 Min Read
LONDON, June 14 (Reuters) - RP Management: * RP Management - Royalty Pharma notes Elan sales process offers shareholders
no certainty * RP-shareholders urged to vote against all four proposals to allow RP’s offer
to move forward
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.